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doi:10.1Background: Few data exist on clinical/imaging characteristics, management, and outcomes of patients with
type A acute dissection and mesenteric malperfusion.
Methods: Patients with type A acute dissection enrolled in the International Registry for Acute Dissection
(IRAD) were evaluated to assess differences in clinical features, management, and in-hospital outcomes
according to the presence/absence of mesenteric malperfusion. A mortality model was used to identify predic-
tors of in-hospital mortality in patients with mesenteric malperfusion.
Results: Mesenteric malperfusion was detected in 68 (3.7%) of 1809 patients with type A acute dissection.
Patients with mesenteric malperfusion were more likely to be older and to have coma, cerebrovascular accident,
spinal cord ischemia, acute renal failure, limb ischemia, and any pulse deficit. They were less likely to undergo
surgical/hybrid treatment (52.9% vs 87.9%) and more likely to receive only medical (30.9% vs 11.6%) or
endovascular (16.2% vs 0.5%) management (P<.001). Overall in-hospital mortality was 63.2% and 23.8%
in patients with and without mesenteric malperfusion, respectively (P<.001). In-hospital mortality of patients
with mesenteric malperfusion receiving medical, endovascular, and surgical/hybrid therapy was 95.2%, 72.7%,
and 41.7%, respectively (P<.001). At multivariate analysis, male gender (odds ratio [OR], 1.7; P ¼ .002), age
(OR, 1.1/y; P¼ .002), and renal failure (OR, 5.9; P¼ .020) were predictors of mortality whereas surgical/hybrid
management (OR, 0.1; P ¼ .005) was associated with better outcome.
Conclusions: Type A acute aortic dissection complicated by mesenteric malperfusion is a rare but ominous
complication carrying a high risk of hospital mortality. Surgical/hybrid therapy, although associated with
2-fold hospital mortality, appears to be associated with better long-term outcomes in the management of type
A acute aortic dissection in this setting. (J Thorac Cardiovasc Surg 2013;145:385-90)he Cardiovascular Surgery Department,a Sant’Orsola-Malpighi Hospital,
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The Journal of Thoracic and CardSupplemental material is available online.Over the past 2 decades, knowledge of natural history, diag-
nosis, and management of acute type A aortic dissection has
markedly improved. Despite this, hospital mortality in pa-
tients with aortic dissection remains substantial, ranging
from 7% to 30%.1-3 Preoperative patients’ characteristics
mostly affect hospital outcomes, with the worst results
being reported in patients with hypotension, tamponade,
and organ malperfusion.4
Although several studies have assessed outcomes of
patients with type A aortic dissection complicated by end-
organ malperfusion syndromes, few have focused on mes-
enteric malperfusion. The International Registry of Acute
Dissection (IRAD) represents a unique opportunity to study
a large group of patients with aortic dissection collected in
18 referral centers worldwide.iovascular Surgery c Volume 145, Number 2 385
Abbreviations and Acronyms
CI ¼ confidence interval
IRAD ¼ International Registry of Acute
Dissection
NS ¼ not significant
OR ¼ odds ratio
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DAims of the present study were to compare clinical/imag-
ing characteristics, management, and outcome of patients
with typeAacute dissectionwith andwithoutmesentericmal-
perfusion and to assess outcomes of patients with mesenteric
malperfusion according to different therapeutic strategies
(surgical/hybrid, endovascular, and exclusively medical).METHODS
Study Population and Data Collection
The rationale andmethodologyof IRADhavebeenpublishedpreviously.5,6
At the time of our study, we examined 1809 consecutive patients with type A
acute dissection enrolled at 18 institutions between December 1995 and
August 2010. Acute type A dissection was defined as any dissection that
involved the ascending aorta and/or aortic arch appearing within 14 days of
the onset of symptoms. The diagnosis of aortic dissection was based on
history, imaging studies, direct visualization at surgery, and/or postmortem
findings. Patients were categorized according to presence/absence of
mesenteric malperfusion, which was defined as any radiologic evidence of
decreased perfusion through the celiac trunk, superior mesenteric artery,
and inferior mesenteric artery with decreased viability or necrosis of the
gut, with or without lactic acidosis, pain, or abdominal distention.
All patients were classified according to 3 different therapeutic strategies:
surgical/hybrid, endovascular, and exclusively medical therapy. A surgical/
hybrid procedurewasdefined as a planned central aortic operation (ascending
aorta/arch replacement) possibly associated with any percutaneous aortic or
branch artery procedure (fenestration, stenting) performed simultaneously
or within the same hospitalization. Endovascular treatment was defined as
any percutaneous aortic or branch artery procedure (fenestration, stenting)
in which any other central surgical procedure was not performed.
IRADdata formswere used to collect 290 clinical variables, including pa-
tient demographics, history, clinical presentation, physical findings, imaging
studies, therapeutic management, in-hospital mortality, and adverse events.
Completed data forms were forwarded to the coordinating center at the
University of Michigan and reviewed for faced validity and completeness.
Statistical Analysis
Continuous variables were expressed as the mean  1 standard devia-
tion or median and Q1-Q3 and categorical variables as percentages. In
all cases, missing data were not defaulted to negative, and denominators
reflect only cases reported.
Univariate analyses between groups were done using c2 tests (or Fisher
exact tests) and Student t tests where appropriate. All P values are 2-sided.
Preoperative and intraoperative variables were first analyzed using
univariate analysis to determine whether any single factor was related to
therapeutic strategy and hospital mortality in all patients and in those
with mesenteric malperfusion. Variables that achieved P values less than
.15 in the univariate analysis were examined using gender-adjusted multi-
variate analysis by forward stepwise logistic regression to estimate the in-
dependent odds ratios (ORs) of factors related to nonsurgical/hybrid
management (all patients and patients with mesenteric malperfusion) and
hospital mortality in patients with mesenteric malperfusion.386 The Journal of Thoracic and Cardiovascular SurgStatistical analysis was performed by SPSS version 18.0 (SPSS, Inc,
Chicago, Ill).RESULTS
Clinical Characteristics of Patients With and
WithoutMesentericMalperfusion (Tables 1, 2, and 3)
Of 3099 consecutive patients with acute aortic dissection
enrolled between December 1995 and August 2010, 1967
(63.5%) had type A dissection. Sixty-eight (3.8%) of
1809 patients with available data had mesenteric
malperfusion.
Compared with those who did not have mesenteric mal-
perfusion, those who did were older (61.8  14.4 vs 57.9
 14.4 years; P ¼ .028) and more likely to have abdominal
(58.5% vs 24.2%; P < .001), leg (35.9% vs 12.0%;
P< .001), and migrating (21.3% vs 12.1%; P ¼ .032)
pain. Patients with mesenteric malperfusion more fre-
quently had coma (10.0% vs 3.1%; P ¼ .003), ischemic
spinal cord damage (6.8% vs 0.8%; P ¼ .002), acute renal
failure (52.2% vs 7.2%; P<.001), limb ischemia (38.5%
vs 9.9%; P < .001), and any pulse deficit (45.8% vs
29.8%; P ¼ .009).
Electrocardiographic evidence of newmyocardial infarc-
tion (8.5% vs 7.2%; P¼ not significant [NS]), left ventric-
ular hypertrophy (24.1% vs 20.9%; P ¼ NS), and low
voltage (5.2% vs 4.5%; P ¼ NS) were similar in patients
with and without mesenteric malperfusion. On imaging
studies, widened mediastinum (52.0% vs 54.1%;
P ¼ NS), pleural effusion (20.8% vs 12.4%; P¼ NS), aor-
tic regurgitation (65.5% vs 53.5%; P ¼ NS), and coronary
artery compromise (16.7% vs 12.4%; P ¼ NS) were
equally present in patients with and without mesenteric
malperfusion.
Computed tomographic angiography, magnetic reso-
nance imaging, and transesophageal echocardiography
were used with similar frequency to assess characteristics
of dissection in patients with and without mesenteric
malperfusion. Angiography was more frequently performed
in patients with mesenteric malperfusion (33.3% vs 11.0%;
P< .001), in whom an overall higher number of imaging
tests were required to complete the diagnostic process
(2.0 0.8 vs 1.6 0.6; P<.001). Despite that, the time de-
lay (hours) between symptom onset and diagnosis was sim-
ilar in patients with and without mesenteric malperfusion
(6.5 vs 5.8; P ¼ NS).
The intimal–medial flap originated more frequently at
the aortic root (62.7% vs 45.2%; P ¼ .005) in patients
with mesenteric malperfusion and at the ascending aorta
(36.5% vs 23.9%; P ¼ .035) in patients without mesen-
teric malperfusion. Patients with mesenteric malperfu-
sion were more likely to have arch vessel involvement
(52.9% vs 35.7%; P ¼ .012) and any renal artery
(70.6% vs 18.0%; P < .001) involvement by the
dissection.ery c February 2013
TABLE 1. Demographics and history of patients with and without mesenteric malperfusion
Variable Mesenteric malperfusion (n ¼ 68) No mesenteric malperfusion (n ¼ 1741) P value
Age, mean (SD), y 61.8  14.4 57.9  14.4 .028
Male (%) 47/68 (69.1) 1171/1741 (67.3) .749
White (%) 54/62 (87.1) 1461/1629 (89.7) .512
Atherosclerosis (%) 16/66 (24.2) 377/1676 (22.5) .739
Diabetes (%) 3/66 (4.5) 96/1669 (5.8) .796
Hypertension (%) 47/66 (71.2) 1208/1693 (71.4) .980
Aortic valve disease (ASþAR) (%) 8/65 (12.3) 63/1672 (12.1) .956
Bicuspid aortic valve (%) 3/53 (5.7) 202/1669 (12.1) .668
Marfan (%) 2/66 (3.0) 74/1687 (4.4) .767
Peripartum (%) — 4/1653 (0.2) 1.000
Cocaine abuse (%) — 19/1656 (1.1) .643
Known aortic aneurysm (%) 5/66 (7.6) 210/1683 (12.5) .260
Prior aortic dissection (%) — 72/1684 (4.3) .110
Iatrogenic dissection (%) 2/65 (3.1) 55/1665 (3.3) 1.000
Prior cardiac surgery (%) 15/65 (23.1) 245/1660 (14.8) .066
History of catheterization/angiography 9/53 (17.0) 155/1390 (11.2) .189
SD, Standard deviation; AS, aortic stenosis; AR, aortic regurgitation.
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Without Mesenteric Malperfusion
All patients. Overall, 86.7% (1567 of 1809) of patients
with acute type A dissection underwent surgical/hybrid
procedures and 1.0% (19 of 1809) and 12.3% (223 of
1809) received endovascular and medical management,
respectively.
On binary logistic regression, preoperative mesenteric
malperfusion (OR, 7.9; 95% confidence interval [CI],
3.229-19.521; P < .001), age more than 70 years (OR,
2.9; 95% CI, 1.782-4.884; P< .001), and female gender
(OR, 2.1; 95% CI, 1.317-3.557; P ¼ .002) were the stron-
gest independent predictors of receiving medical/endovas-
cular management.
Patients with and without mesenteric malperfusion
(Table 4). Patients with mesenteric malperfusion were
less likely to undergo surgical/hybrid treatment (52.9% vs
87.9%; P < .001) and more likely to receive medical
(30.9% vs 11.6%; P< .001) or endovascular (16.2% vs
0.5%;P<.001) management, when compared with patients
without mesenteric malperfusion.
In surgically managed patients, the extent of aortic re-
placement, rate of associated cardiac procedures (8.6% vs
12.6%; P ¼ NS), and rate of open aortic anastomosis
(84.0% vs 94.1%; P ¼ NS) were equally distributed in pa-
tients with and without mesenteric malperfusion. Patients
with mesenteric malperfusion were more likely to require
an associated peripheral vascular surgical procedure
(11.1% vs 3.5%; P ¼ .018) (Table E1).
Patients with mesenteric malperfusion. Preoperatively,
clinical and dissection imaging features were similar in
patients receiving surgical/hybrid, endovascular, or medical
treatment, except for older age being more frequent
in patients receiving medical management (medical vsThe Journal of Thoracic and Casurgical/hybrid: 65.0  15.9 vs 54.1  13.1 years;
P ¼ .007; medical vs endovascular: 65.0  15.9 vs 56.6
 11.1 years; P ¼ NS; surgical/hybrid vs endovascular:
54.1  13.1 vs 56.6  11.1 years; P ¼ NS). Severe comor-
bid illness was reported as a contraindication to surgical re-
pair in all cases and, on logistic regression, age greater than
70 years (OR, 5.2; 95% CI, 0.741-36.526; P ¼ .097)
emerged as the only independent predictor of medical/en-
dovascular management.
Hospital Results
Patients with and without mesenteric malperfusion
(Table 5). Hospital mortality was 63.2% (43 of 68) and
23.8% (414 of 1741) in patients with and without mesen-
teric malperfusion, respectively (P<.001).
On multiple logistic regression, mesenteric malperfusion
(OR, 2.520; 95% CI, 1.127-5.633), age greater than 70
years (OR, 2.327; 95% CI, 1.680-3.222), migrating pain
(OR, 1.747; 95% CI, 1.126-2.710), hypotension/shock/
tamponade (OR, 2.636; 95% CI, 1.915-3.629), renal failure
(OR, 2.076; 95% CI, 1.466-2.940), and abnormal electro-
cardiogram (OR, 1.568; 95% CI, 1.113-2.210) emerged
as independent predictors of in-hospital mortality.
Postoperative occurrence of new major brain injuries
(stroke or coma), myocardial ischemic complications, and
cardiac tamponade were equally observed in patients with
and without mesenteric malperfusion. Patients with mesen-
teric malperfusion were more likely to have postoperative
renal failure (44.4% vs 16.8%; P<.001) and limb ischemia
(9.6% vs 3.1%; P ¼ .009).
Patients with mesenteric malperfusion. In patients with
mesenteric malperfusion, hospital mortality was 95.2%
(20 of 21) after medical management, 72.7% (8 of 11) after
endovascular treatment, and 41.7% (15 of 36) afterrdiovascular Surgery c Volume 145, Number 2 387
TABLE 2. Clinical presentation of patients with and without mesenteric malperfusion
Variable
Mesenteric malperfusion
(n ¼ 68)
No mesenteric
malperfusion (n ¼ 1741) P value
Time from symptom onset to diagnosis (h) 6.5 (1.3-23.8) 5.8 (1.9-24.0) .325
Time from diagnosis to surgical/hybrid or endovascular treatment (h) 9.0 (2.3-24.0) 4.8 (2.1-18.1) .193
Time from symptom onset to surgical/hybrid or endovascular treatment (h) 19.1 (8.8-65.0) 14.8 (6.8-40.5) .743
Chest pain (%) 48/68 (70.6%) 1348/1672 (80.6%) .042
Anterior (%) 43/55 (78.2) 1075/1378 (78.0) .976
Posterior (%) 15/44 (34.1) 487/1274 (38.2) .579
Back pain (%) 32/66 (48.5) 682/1622 (42.0) .299
Abdominal pain (%) 38/65 (58.5) 389/1610 (24.2) <.001
Leg pain (%) 23/64 (35.9) 191/1593 (12.0) <.001
Quality of pain
Migrating (%) 13/61 (21.3) 189/1563 (12.1) .032
Radiating (%) 24/63 (38.1) 560/1583 (35.4) .658
Pain severity (%)
Mild (%) – 117/1350 (8.7) .304
Severe (%) 40/52 (76.9) 1008/1350 (74.7) .713
Worst ever (%) 12/52 (23.1) 225/1350 (16.7) .226
Abrupt onset of pain (%) 59/65 (90.8) 1335/1619 (82.5) .082
Febrile 4/54 (7.4) 34/1319 (2.6) .059
Hypotension/shock/tamponade (%) 18/64 (28.1) 449/1628 (27.6) .924
Hypertension (%) 22/64 (34.4) 493/1628 (30.3) .485
Syncope (%) 8/67 (11.9) 297/1644 (18.1) .199
Cerebrovascular accident (%) 6/63 (9.5) 84/1624 (5.2) .132
Coma (%) 6/60 (10.0) 50/1626 (3.1) .003
Ischemic spinal cord damage (%) 4/59 (6.8) 13/1628 (0.8) .002
Myocardial ischemia/infarction (%) 12/66 (18.2) 193/1733 (11.1) .077
Cardiac heart failure (%) 9/63 (14.3) 127/1670 (7.6) .053
Acute renal failure (%) 35/67 (52.2) 124/1729 (7.2) <.001
Limb ischemia (%) 25/65 (38.5) 171/1728 (9.9) <.001
Any pulse deficit (%) 27/59 (45.8) 394/1321 (29.8) .009
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mesenteric malperfusion who died, causes of death were vis-
ceral ischemia (n ¼ 15; 34.9%), neurologic (n ¼ 2; 7.0%),
multiorgan failure (n ¼ 5; 11.6%), cardiac (n ¼ 2; 4.7%),
tamponade (n¼ 2; 4.7%), and not specified (n¼ 15; 44.9%).
At binary logistic regression, surgical/hybrid manage-
ment (OR, 0.1; 95% CI, 0.028-0.539; P ¼ .005) resulted
as a protective factor for hospital mortality, whereas male
gender (OR, 1.7; 95% CI, 0-338-7.397; P ¼ .484), age
(OR, 1.112; 95% CI, 1.041-1.188; P ¼ .002), and preoper-
ative renal failure (OR, 5.989; 95% CI, 1.328-26.182;
P¼ .020) were associated with increased hospital mortality.
DISCUSSION
Aortic dissection remains one of the most lethal cardio-
vascular diseases, and end-organ malperfusion syndromes,
which occur in approximately in one-third of patients,4
are associated with elevated mortality and dismal postoper-
ative outcomes.7-9
Among different ischemic end-organ complications oc-
curring at the onset of dissection, mesenteric malperfusion
is one of the most insidious and therefore challenging for di-
agnostic and management decision making.10388 The Journal of Thoracic and Cardiovascular SurgOur data show that mesenteric malperfusion is a rare com-
plication of acute dissection and that, very commonly, is asso-
ciated with clinical or imaging signs of other organ injury or
malperfusion. In our series of 1809 patients with typeA acute
dissection, only 68 (3.8%) met our definition of mesenteric
malperfusion and approximately 30% of them showed clini-
cal symptoms or signs of neurologic complications, 52.2%
had acute renal failure, and30%had limb ischemia.Although
thementioned associated complicationsmay not involvemal-
perfusion as the only underlying pathogenetic mechanism,
imaging data, showing extremely high rates of arch vessel
(52.9%) and any renal artery involvement (70.6%) by the dis-
section, support the idea thatmalperfusion plays an important
role and that, when it occurs, it is likely to involve more than
onevascular territory. Interestingly, the observation that about
40% of patients with mesenteric ischemia did not have ab-
dominal pain, whereas about 20% of patientswithoutmesen-
teric malperfusion had pain, confirms that abdominal pain is
a nonspecific symptom of acute mesenteric ischemia.11,12
Moreover, the typically progressive nature of both the aortic
dissecting disease and malperfusive complication, in
addition to the potential different times of patients’
presentation with different degrees of bowel ischemia, mayery c February 2013
TABLE 3. Characteristics of dissection in patients with and without mesenteric malperfusion
Variable Mesenteric malperfusion (n ¼ 68) No mesenteric malperfusion (n ¼ 1741) P value
Origin of dissection flap
Sinotubular junction (%) 5/67 (7.5) 195/1628 (12.0) .262
Aortic root (%) 42/67 (62.7) 736/1628 (45.2) .005
Ascending (%) 16/67 (23.9) 594/1628 (36.5) .035
Arch (%) 3/67 (4.5) 66/1628 (4.1) .863
False lumen patency
Patent (%) 38/50 (76.0) 753/1063 (70.8) .431
Partial thrombosis (%) 10/50 (20.0) 208/1063 (19.6) .940
Complete thrombosis (%) 2/50 (4.0) 102/1063 (9.6) .184
Distal communication (%) 17/44 (38.6) 243/1015 (23.9) .027
Arch vessel involvement (%) 27/51 (52.9) 429/1203 (35.7) .012
Any renal artery involvement (%) 48/68 (70.6) 309/1716 (18.0) <.001
Coronary arteries compromised (%) 8/48 (16.7) 156/1262 (12.4) .376
Aortic regurgitation (%) 36/55 (65.5) 773/1445 (53.5) .081
Aortic measurements
Aortic annulus (cm) 2.6 (2.3-2.9) 2.5 (2.3-2.9) .878
Aortic root (cm) 4.5 (3.8-5.9) 4.2 (3.7-5.0) .511
Ascending aorta (widest) (cm) 4.9 (4.5-5.5) 5.0 (4.4-5.8) .539
Aortic arch (cm) 4.0 (3.5-4.4) 3.6 (3.2-4.1) .252
Descending aorta (widest) (cm) 3.3 (3.0-4.2) 3.4 (3.0-3.8) .875
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which is slightly superior to the 25% reported in literature.12
In IRAD, patients with mesenteric malperfusion were less
likely to undergo surgical treatment and more likely to re-
ceive a recognized suboptimal therapeutic management,
namely, medical or endovascular therapy. Moreover, such
a difference in therapeutic management was striking: about
50%of patientswithmesentericmalperfusiondid not receive
surgical therapy against 12% of patients without. Accord-
ingly, binary logistic regression confirmed these observations
by indicating mesenteric malperfusion as the strongest pre-
dictor of medical therapy in the overall series (OR, 7.9).
These data clearly reflect surgeons’ attitudes to avoid sur-
gery in patients with severe preoperative comorbidities and
indicate that mesenteric malperfusion, among all preopera-
tive dissection-related complications, is considered as (one
of) the most threatening.
Almost two-thirds of patients with mesenteric malperfu-
sion died during hospitalization, almost 3 times the number
of those patients without the mentioned complication
(63.2% vs 23.8%).TABLE 4. Therapeutic strategies for patients with and without mesenteric
Therapeutic strategies Mesenteric malperfus
Surgical/Hybrid (%) 36/68 (52.9
Open surgeryþaortic fenestration (%) 0/4 (0.0)
Open surgeryþaortic stenting (%) 2/4 (50.0
Open surgeryþaortic stenting and fenestration 2/4 (50.0
Endovascular (%) 11/68 (16.2
Aortic fenestration (%) 2/11 (18.2
Aortic stenting (%) 2/11 (18.2
Aortic stenting and fenestration (%) 7/11 (63.6
Exclusively medical (%) 21/68 (30.9
The Journal of Thoracic and CaHowever, when assessing hospital mortality according
to different therapeutic management, in patients with mes-
enteric malperfusion an interesting scenario becomes evi-
dent: medical and endovascular therapies were associated
with dismal mortality rates (95.2% and 72.7%, respec-
tively), whereas surgical/hybrid therapy was associated
with a significantly higher survival of 41.7%.
Accordingly, our binary logistic regression indicated that
surgical/hybrid therapy for patients deemed operable by the
treating facility was associated with the best survival in pa-
tients with mesenteric malperfusion, even after adjusting for
gender, age, and renal failure. This is likely due to both pa-
tient selection and the potential benefit of definitive repair.
When surgical treatment is used, operative timing and
potential use of percutaneous procedures (fenestration/
stenting) to address branch artery obstruction still represent
greatly debated issues.
Some authors,13,14 given the unpredictable nature of acute
typeA dissection and its ever-present potential for rupture, ad-
vocate immediate correction of malperfusion syndromes by
replacing the ascending and/or transverse aortic arch, thusmalperfusion
ion (n ¼ 68) No mesenteric malperfusion (n ¼ 1741) P value
) 1531/1741 (87.9) <.001
1/14 (7.1) 1.000
) 12/14 (85.7) .197
) 1/14 (7.1) .108
) 8/1741 (0.5) <.001
) 2/8 (25.0) 1.000
) 2/8 (25.0) 1.000
) 4/8 (50.0) .658
) 202/1741 (11.6) <.001
rdiovascular Surgery c Volume 145, Number 2 389
TABLE 5. In-hospital mortality and complications for patients with type A acute dissection with and without mesenteric malperfusion
Mesenteric malperfusion (n ¼ 68) No mesenteric malperfusion (n ¼ 1741) P value
Mortality (%) 43/68 (63.2) 414/1741 (23.8) <.001
Major brain injury (comaþstroke) (%) 5/42 (11.9) 129/1532 (8.4) .575
Spinal cord injury (%) 1/45 (2.2) 13/1551 (0.8) .331
Myocardial infarction/ischemia (%) 4/59 (6.8) 96/1689 (5.7) .772
Acute renal failure (%) 20/45 (44.4) 286/1701 (16.8) <.001
Limb ischemia (%) 5/52 (9.6) 52/1695 (3.1) .025
Cardiac tamponade (%) 5/57 (8.8) 91/1659 (5.5) .370
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selected patients showing clinical deterioration owing to
established end-organ ischemic dysfunction, suggest alterna-
tive management strategies such as delayed central aortic op-
eration after percutaneous end-organ blood flow restoration.
This approach,which certainly takes into account thepotential
for aortic rupture before ascending aortic repair has been ac-
complished, finds its rationale in the predominant prognostic
weight of theend-organdysfunctionand in the suboptimal sur-
gical outcomes reported in this setting.
Our analysis does not allow us to distinguish the best
therapeutic option between the aforementioned approaches.
However, IRAD data show that hybrid management (central
aortic operation plus percutaneous treatment of mesenteric
malperfusion) was applied in only a very few cases and that
immediate surgical repair of the proximal dissected aorta
still represents the most common therapeutic approach for
patients with type A acute dissection complicated by mes-
enteric malperfusion.
Limitations and Strengths
Our definition of mesenteric malperfusion does not allow
distinguishing patientswith different degrees of intestinal is-
chemic injury As a consequence, differences in clinical fea-
tures, management, and outcomes of patients according to
the presence/absence of intestinal infarction could not be
captured, and the comparison between surgical/hybrid, en-
dovascular, andmedicalmanagementmight have been influ-
enced by a selection bias in the therapeutic referral process.
Data on intestinal surgical procedures are not available in
the IRAD registry. Thus, the clinical relevance and prognos-
tic implications of concomitant abdominal surgery could
not be evaluated.
Current knowledge about mesenteric malperfusion is
based on case studies with an extremely limited number
of patients, or extrapolated by larger reports including dif-
ferent organ malperfusion syndromes. Our study, analyzing
the largest series of patients with mesenteric malperfusion,
may help shed light on this high-risk group of patients.
CONCLUSIONS
Our data showed that patients with mesenteric malperfu-
sion are older and frequently have associated neurologic, re-
nal, and limb dissection–related complications. Mesenteric390 The Journal of Thoracic and Cardiovascular Surgmalperfusion is a rare but ominous complication carrying
a 3-fold higher risk of hospital mortality. When compared
with different therapeutic treatments, surgical/hybrid ther-
apy appears to be associated with better outcomes.References
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TABLE E1. Surgical procedures for patients with type A acute dissection with and without mesenteric malperfusion
Mesenteric malperfusion (n ¼ 68) No mesenteric malperfusion (n ¼ 1741) P value
Extent of aortic replacement
Root (%) 10/30 (33.3) 482/1339 (36.0) .764
Ascending aorta (%) 28/36 (77.8) 1380/1483 (93.1) .001
Partial arch (%) 10/37 (27.0) 564/1426 (39.6) .123
Complete arch (%) 5/37 (13.5) 204/1435 (14.2) 1.000
Open procedure (%) 21/25 (84.0) 866/920 (94.1) .061
Associated procedures (%)
AVR (%) 8/34 (23.5) 394/1456 (27.1) .647
CABG (%) 3/35 (8.6) 173/1446 (12.0) .791
MVR (%) – 10/1449 (0.7) 1.000
Reoperation (%) 5/34 (14.7) 189/1429 (13.2) .797
Peripheral vessels replaced 4/36 (11.1) 51/1440 (3.5) .018
AVR, Aortic valve replacement; CABG, coronary artery bypass grafting; MVR, mitral valve repair/replacement.
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